{"id":"NCT03395639","sponsor":"Daiichi Sankyo","briefTitle":"Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease","officialTitle":"An Open-label, Randomised, Parallel-group, Multicentre, Observational Trial to Evaluate Safety and Efficacy of Edoxaban Tosylate in Children From 38 Weeks Gestational Age to Less Than 18 Years of Age With Cardiac Diseases at Risk of Thromboembolic Events","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-05-15","primaryCompletion":"2021-12-03","completion":"2021-12-03","firstPosted":"2018-01-10","resultsPosted":"2022-07-26","lastUpdate":"2022-07-26"},"enrollment":168,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Cardiac Disease"],"interventions":[{"type":"DRUG","name":"Edoxaban","otherNames":["Lixiana","Savaysa"]},{"type":"DRUG","name":"Standard of Care (SOC)","otherNames":["Warfarin/heparin","Enoxaparin"]}],"arms":[{"label":"Edoxaban","type":"EXPERIMENTAL"},{"label":"Standard of Care (SOC)","type":"ACTIVE_COMPARATOR"}],"summary":"A committee will judge the safety and effectiveness of edoxaban and the regular treatment (standard of care).\n\nAll children in the study will receive free treatment. They will have a 2 in 3 chance to receive edoxaban, and a 1 in 3 chance to receive the standard of care for preventing blood clots.\n\nThe study will find out if edoxaban is safer and more effective than the standard of care.","primaryOutcome":{"measure":"Number of Participants With Adjudicated Bleeding Events Within the Main Treatment Period","timeFrame":"Date of first dose of study drug up to the Month 4 or to the date of last dose of study drug if study treatment was discontinued, whichever was earlier","effectByArm":[{"arm":"Edoxaban","deltaMin":1,"sd":null},{"arm":"Standard of Care (SOC)","deltaMin":1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"1 Day","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":48,"countries":["United States","Austria","Canada","Croatia","Egypt","France","Hungary","India","Israel","Lebanon","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["36328157"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":109},"commonTop":["Cough","Pyrexia","Headache","Cough","Upper respiratory tract infection"]}}